Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing
- PMID: 18427125
- DOI: 10.1161/CIRCULATIONAHA.107.189473
Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing
Erratum in
- Circulation. 2009 Aug 18;120(7):e55-9
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
